295 related articles for article (PubMed ID: 36322366)
1. Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review.
Khan IA; Saraya A
J Gastrointest Cancer; 2023 Sep; 54(3):720-730. PubMed ID: 36322366
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
Seyhan AA
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
[TBL] [Abstract][Full Text] [Related]
3. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma-A Review of the Literature.
Wnuk J; Strzelczyk JK; Gisterek I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982210
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer.
Peng C; Wang J; Gao W; Huang L; Liu Y; Li X; Li Z; Yu X
Int J Med Sci; 2021; 18(3):660-671. PubMed ID: 33437201
[No Abstract] [Full Text] [Related]
6. Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review.
Xue J; Jia E; Ren N; Lindsay A; Yu H
Onco Targets Ther; 2019; 12():6665-6684. PubMed ID: 31692495
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125a-3p, -4530, and -92a as a Potential Circulating MicroRNA Panel for Noninvasive Pancreatic Cancer Diagnosis.
Seyed Salehi A; Parsa-Nikoo N; Roshan-Farzad F; Shams R; Fathi M; Asaszadeh Aghdaei H; Behmanesh A
Dis Markers; 2022; 2022():8040419. PubMed ID: 36254252
[TBL] [Abstract][Full Text] [Related]
8. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
[TBL] [Abstract][Full Text] [Related]
9. A machine learning approach identified a diagnostic model for pancreatic cancer through using circulating microRNA signatures.
Alizadeh Savareh B; Asadzadeh Aghdaie H; Behmanesh A; Bashiri A; Sadeghi A; Zali M; Shams R
Pancreatology; 2020 Sep; 20(6):1195-1204. PubMed ID: 32800647
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review).
Subramani R; Gangwani L; Nandy SB; Arumugam A; Chattopadhyay M; Lakshmanaswamy R
Int J Oncol; 2015 Oct; 47(4):1203-10. PubMed ID: 26314882
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs: Biomarkers of disease.
Wu Y; Li Q; Zhang R; Dai X; Chen W; Xing D
Clin Chim Acta; 2021 May; 516():46-54. PubMed ID: 33485903
[TBL] [Abstract][Full Text] [Related]
12. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
[TBL] [Abstract][Full Text] [Related]
13. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer.
Deng B; Wang M; Liu Z
Medicine (Baltimore); 2020 Sep; 99(38):e22261. PubMed ID: 32957376
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in Pancreatic Cancer: Advances in Biomarker Discovery and Therapeutic Implications.
Madadjim R; An T; Cui J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612727
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
O'Neill RS; Stoita A
World J Gastroenterol; 2021 Jul; 27(26):4045-4087. PubMed ID: 34326612
[TBL] [Abstract][Full Text] [Related]
16. Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized Algorithm.
Lee J; Lee HS; Park SB; Kim C; Kim K; Jung DE; Song SY
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498271
[TBL] [Abstract][Full Text] [Related]
17. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.
Bestari MB; Joewono IR; Syam AF
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540782
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.
Chhatriya B; Mukherjee M; Ray S; Sarkar P; Chatterjee S; Nath D; Das K; Goswami S
BMC Cancer; 2019 Dec; 19(1):1175. PubMed ID: 31795960
[TBL] [Abstract][Full Text] [Related]
20. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]